Page 11234..10..»

Category : Nanomedicine

Nanomedicine | medicine | Britannica.com

Nanomedicine, branch of medicine that seeks to apply nanotechnologythat is, the manipulation and manufacture of materials and devices that are smaller than 1 nanometre [0.0000001 cm] in sizeto the prevention of disease and to imaging, diagnosis, monitoring, treatment, repair, and regeneration of biological systems.

Although nanomedicine remains in its early stages, a number of nanomedical applications have been developed. Research thus far has focused on the development of biosensors to aid in diagnostics and vehicles to administer vaccines, medications, and genetic therapy, including the development of nanocapsules to aid in cancer treatment.

An offshoot of nanotechnology, nanomedicine is an emerging field and had garnered interest as a site for global research and development, which gives the field academic and commercial legitimacy. Funding for nanomedicine research comes both from public and private sources, and the leading investors are the United States, the United Kingdom, Germany, and Japan. In terms of the volume of nanomedicine research, these countries are joined by China, France, India, Brazil, Russia, and India.

Working at the molecular-size scale, nanomedicine is animated with promises of the seamless integration of biology and technology, the eradication of disease through personalized medicine, targeted drug delivery, regenerative medicine, as well as nanomachinery that can substitute portions of cells. Although many of these visions may not come to fruition, some nanomedicine applications have become reality, with the potential to radically transform the practice of medicine, as well as current understandings of the health, disease, and biologyissues that are of vital importance for contemporary societies. The fields global market share totalled some $78 billion dollars in 2012, driven by technological advancements. By the end of the decade, the market is expected to grow to nearly $200 billion.

Nanomedicine derives much of its rhetorical, technological, and scientific strength from the scale on which it operates (1 to 100 nanometers), the size of molecules and biochemical functions. The term nanomedicine emerged in 1999, the year when American scientist Robert A. Freitas Jr. published Nanomedicine: Basic Capabilities, the first of two volumes he dedicated to the subject.

Extending American scientist K. Eric Drexlers vision of molecular assemblers with respect to nanotechnology, nanomedicine was depicted as facilitating the creation of nanobot devices (nanoscale-sized automatons) that would navigate the human body searching for and clearing disease. Although much of this compelling imagery still remains unrealized, it underscores the underlying vision of doctors being able to search and destroy diseased cells, or of nanomachines that substitute biological parts, which still drives portrayals of the field. Such illustrations remain integral to the field, being used by scientists, funding agencies, and the media alike.

Attesting to the fields actuality are numerous dedicated scientific and industry-oriented conferences, peer-reviewed scientific journals, professional societies, and a growing number of companies. However, nanomedicines identity, scope, and goals are a matter of controversy. In 2006, for instance, the prestigious journal Nature Materials discussed the ongoing struggle of policy makers to understand if nanomedicine is a rhetorical issue or a solution to a real problem. This ambivalence is reflected in the numerous definitions of nanomedicine that can be found in scientific literature, that range from complicated drugs to the above mentioned nanobots. Despite the lack of a shared definition, there is a general agreement that nanomedicine entails the application of nanotechnology in medicine and that it will profoundly impact medical practice.

A further topic of debate is nanomedicines genealogy, in particular its connections to molecular medicine and nanotechnology. The case of nanotechnology is exemplary: on one hand, its potentialin terms of science but also in regard to funding and recognitionis often mobilized by nanomedicine proponents; on the other, there is an attempt to distance nanomedicine from nanotechnology, for fear of being damaged by the perceived hype that surrounds it. The push is then for nanomedicine to emerge not as a subdiscipline of nanotechnology but as a parallel field.

Although nanomedicine research and development is actively pursued in numerous countries, the United States, the EU (particularly Germany), and Japan have made significant contributions from the fields outset. This is reflected both in the number of articles published and in that of patents filed, both of which have grown exponentially since 2004. By 2012, however, nanomedicine research in China grew with respect to publications in the field, and the country ranked second only to the United States in the number of research articles published.

In 2004, two U.S. funding agenciesthe National Institutes of Health and the National Cancer Instituteidentified nanomedicine as a priority research area allocating $144 million and $80 million, respectively, to its study. In the EU meanwhile, public granting institutions did not formally recognize nanomedicine as a field, providing instead funding for research that falls under the headers of nanotechnology and health. Such lack of coordination had been the target of critiques by the European Science Foundation (ESF), warning that it would result in lost medical benefits. In spite of this, the EU ranked first in number of nanomedicine articles published and in 2007 the Seventh Framework Programme (FP7) allocated 250 million to nanomedicine research. Such work has also been heavily funded by the private sector. A study led by the European Science and Technology Observatory found that over 200 European companies were researching and developing nanomedicine applications, many of which were coordinating their efforts.

Much of nanomedicine research is application oriented, emphasizing methods to transfer it from the laboratory to the bedside. In 2005 the ESF pointed to four main subfields in nanomedicine research: analytical tools and nanoimaging, nanomaterials and nanodevices, novel therapeutics and drug delivery systems, and clinical, regulatory, and toxicological issues. Research in analytical tools and nanoimaging seeks to develop noninvasive, reliable, cheap, and highly sensitive tools for in vivo diagnosis and visualization. The ultimate goal is to create fully functional mobile sensors that can be remotely controlled to conduct in vivo, real-time analysis. Research on nanomaterials and nanodevices aims to improve the biocompatibility and mechanical properties of biomaterials used in medicine, so as to create safer implants, substitute damaged cell parts, or stimulate cell growth for tissue engineering and regeneration, to name a few. Work in novel therapeutics and drug delivery systems strives to develop and design nanoparticles and nanostructures that are noninvasive and can target specific diseases, as well as cross biological barriers. Allied with very precise means for diagnosis, these drug delivery systems would enable equally precise site-specific therapeutics and fewer side effects. The area of drug delivery accounts for a large portion of nanomedicines scientific publications.

Finally, the subfield of clinical, regulatory, and toxicological issues lumps together research that examines the field as a whole. Questions of safety and toxicology are prevalent, an issue that is all the more important given that nanomedicine entails introducing newly engineered nanoscale particles, materials, and devices into the human body. Regulatory issues revolve around the management of this newness, with some defending the need for new regulation, and others the ability of systems to deal with it. This subfield should also include other research by social scientists and humanists, namely on the ethics of nanomedicine.

Combined, these subfields build a case for preventive medicine and personalized medicine. Building upon genomics, personalized medicine envisions the possibility of individually tailored diagnostics and therapeutics. Preventive medicine takes this notion further, conjuring the possibility of treating a disease before it manifests itself. If realized, such shifts would have radical impacts on understandings of health, embodiment, and personhood. Questions remain concerning the cost and accessibility of nanomedicine and also about the consequences of diagnostics based on risk propensity or that lack a cure.

Read more from the original source:
Nanomedicine | medicine | Britannica.com

Recommendation and review posted by Alexandra Lee Anderson

EUNCL | Nanomedicine Characterisation Laboratory

European Nanomedicine Characterisation Laboratory

Our Mission is to provide a trans-disciplinary testing infrastructure covering a comprehensive set of preclinical characterisation assays (physical, chemical, in-vitro and in-vivo biological testing) allowing researchers to fully comprehend the bio distribution, metabolism, pharmacokinetics, safety profiles and immunological effects of their Med-NPs.

We are fostering the use and deployment of standard operating procedures (SOPs), benchmark materials, and quality management for the preclinical characterisation of Med-NPs (nanoparticles used for medical applications).

As nanomedicine is a fast evolving field of research, it is a key objective for EUNCL to constantly refine and adapt its assay portfolio and processes in order maintain the provision of state-of-the-art TNA to the scientific community. Therefore, we will progressively implement additional assays to increase our characterisation capacity, for instance in terms of medical application or route of administration.

The emphasis of the EUNCL is to serve as a nexus for trans-disciplinary research, development and clinical applications of nanotechnology. Therefore, lessons-learned, best practices, knowledge, tools and methods will be made available to the scientific community such as academic researchers, industry, regulatory bodies, metrology institutes and others. However, care will be taken to ensure that proprietary information and materials disclosed to the EUNCL by the TNA users are protected.

Follow this link:
EUNCL | Nanomedicine Characterisation Laboratory

Recommendation and review posted by Alexandra Lee Anderson

Regenerative Nanomedicine Lab – yimlab.com

Our recent research article “In-vitro Topographical Model of Fuchs Dystrophy for Evaluation of Corneal Endothelial Cell Monolayer Formation” appeared on theBack cover of Advanced Healthcare Materials latest issue.

Several diseases have been known to be caused by microstructural changes in the extracellular microenvironment. Therefore, the knowledge of the interaction of cells with the altered extracellular micro-structures or surface topography is critical to develop a better understanding of the disease for therapeutic development. One such disease is Fuchs corneal endothelial dystrophy (FED). FED is the primary disease and major reason of corneal endothelial cell death. If left untreated, corneal blindness will be resulted; thus, FED is the leading indication for corneal transplantation. In the USA, 4% of population over the age of 40 is believed to have compromised corneal endothelium due to FED, which will further increase due to increasing life expectancy and rapidly ageing population. A diagnostic clinical hallmark of FED is the development of discrete pillar or dome-like microstructures on the corneal endothelial basement membrane (Descemet membrane). These microstructures are called corneal guttata or guttae. Cell therapies have been proposed as an alternative treatment method for Fuchs dystrophy patients. However, currently, no in-vitro or in-vivo FED disease model is available to study the cell therapies before clinical trials.

In this study, the pathological changes in the micro-structure of basement membranes resulting from FED disease was analyzed, to identify geometrical dimension to develop an in-vitro disease model of synthetic corneal guttata pillars/domes by using microfabrication techniques. This model was used to study the monolayer formation of donor-derived human corneal endothelial cells to test the effectiveness of the corneal endothelial cell regenerative therapies. The results suggest that the corneal cell therapies may not be equally effective for patients at different stages of disease progression. The pre-existing guttata in patients could interfere with the cells thus hampering monolayer formation within the eye. Surgical removal of the guttata from the diseased Descemet membrane prior to cell regenerative therapy could increase the success rate of monolayer formation, which could potentially increase the chances of cell therapy success. This study also demonstrate how biomaterial design can be employed to mimic the pathological microstructural changes in basement membranes for better understanding of cellular responses in disease conditions.

The rest is here:
Regenerative Nanomedicine Lab – yimlab.com

Recommendation and review posted by Alexandra Lee Anderson

Top Nanomedicine Conferences|DrugDelivery meetings …

About Us

International Conference and Exhibition on Nanomedicine and Drug Delivery May 21-23, 2018 Tokyo, Japan

ConferenceSeries Ltdis a renowned organization that organizes highly notablePharmaceutical Conferencesthroughout the globe. Currently we are bringing forth2ndInternational Conference on Nanomedicine and Drug Delivery(NanoDelivery 2018) scheduled to be held duringMay 21-23, 2018 at Tokyo, Japan. The conferenceinvites all the participants across the globe to attend and share their insights and convey recent developments in the field of Nanomedicine and Drug Delivery.

ConferenceSeries Ltdorganizes aconference seriesof 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientificsocietiesand publishes 700+Open access Journalswhich contains over 50000 eminent personalities, reputed scientists as editorial board members.

2018 Highlights:

Nanomedicine and drugdelivery will account for 40% of a $136 billion nanotechnology-enabled drug delivery market by 2021. We forecast the total market size in 2021 to be US$136 billion, with a 60/40 split between nano medicine and drug delivery respectively, although developing new targeted delivery mechanisms may allow more value to be created for companies and entrepreneurs.

However, the Asia-Pacific region is expected to grow at a faster CAGR owing to presence of high unmet healthcare needs, research collaborations and increase in nanomedicine research funding in emerging economies such as Japan, China, India and other economies in the region. Japan is expected to surpass the United States in terms of nanotechnology funding in the near future, which indicates the growth offered by this region.This conference seeks to showcase work in the area of Nanomedicine, Drug Delivery Systems, and nanotechnology, Nanobiothechnology, particularly related to drug delivery.

For More PS:https://nanomedicine.pharmaceuticalconferences.com/

(Click here for any queries)

Nanomedicine and drugdelivery can address one of the greatest challenges in the post-genomic era of the 21st century making the essential connections between Academics and industry professionals.

To meet these challenges, the field of Nanomedicine and drugdelivery has undergone exponential growth during the last 5 years. Technologies such as Personalized Nanomedicine, Design of Nanodrugs, Synthesis of Nanoparticles for Drug Delivery, Regenerative Medicine and Tissue Engineering, Nanomedicines and Biomedical applications, Nanomaterials for drug delivery, Regulatory Aspects Towards Approval of Nanomedicine, NanoPharmaceutical, Industry and Market processing and drug delivery promise to transform the world of Advanced nanomedicines and drug delivery much in the same way that integrated and transformed the world of pharmaceutical sciences.

Nanodelivery 2018 has everything you need:

Open panel discussions: Providing an open forum with experts from academia and business to discuss on current challenges in nanomedicine and drug delivery, where all attendees can interact with the panel followed by a Q&A session.

Speaker and poster presentations: Providing a platform to all academicians and industry professionals to share their research thoughts and findings through a speech or a poster presentation.

Editorial board meeting: Discussing on growth and development of open access Nanomedicine and drugdelivery International Journals and recruiting board members and reviewers who can support the journal.

Round table meetings: Providing a platform where industry professionals meet academic experts.

Over 50+ organizations and international pavilions will be exhibiting at the Nanodelivery 2018 conference and Exhibition. Exhibitors will include equipment manufacturers and suppliers, systems providers, finance and investment firms, R&D companies, project developers, trade associations, and government agencies.

In addition to the products and services you will see at the Nanodelivery Exhibition, you will have access to valuable content, including Keynote Presentations, Product Demonstrations and Educational Sessions from todays industry leaders.

The Nanodelivery 2018 has everything you need, all under one roof, saving you both time and money. It is the event you cannot afford to miss!

Who’s Coming to Nanodelivery 2018?

The field ofNano Deliverynow has pivotal roles in electronics, biology and medicine. Its application can be appraised, as it involves the materials to be designed at atomic and molecular level. Due to the advantage of their size, nanospheres have been shown to be robustdrug delivery systemsand may be useful for encapsulating drugs and enabling more precise targeting with a controlled release. In this review specifically, we highlight the recent advances of this technology for medicine and drug delivery systems. Nanomaterialsrange from 10200 nm up to a few micrometres in size, and include nano- and microparticles, nanotubes and quantum dots.

Nanotechnological devices are made from metals, polymers, lipids and organic substances as well as from macromolecules such as dendrimers, antibodies, micelles, liposomes and nanofibers. Nanomedicine makes use of these nanostructures for diagnostic or therapeutic applications in all fields of medicine, using them for drug delivery, biosensors, neuro-electronic interfaces, in vivo imaging, and cell-specific molecular interactions, where “cell repair machines” could revolutionize medicine and the medical field. Asdrug delivery systems,nanoparticlescan be designed to improve the pharmacological and therapeutic properties of drugs. The strength of nanoparticulate drug delivery systems is their ability to alter thepharmacokineticsand biodistribution of drugs.

ConferenceSeries Ltdorganizes aconference seriesof 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops in USA, Europe & Asia with support from 1000 morescientificsocietiesand publishes 700+Open access journalswhich contains over 30000 eminent personalities, reputed scientists as editorial board members.

Track 1:Advanced Nanomedicine

Advanced Nanomedicineseeks to deliver a valuable set of research tools and clinically useful devices. The pharmaceutical industry is developing new commercial applications that may include advanced drug delivery systems, new therapies, andNanomaterials for Imaging and Drug Delivery. Another active and very much related area of research is the investigation of toxicity and environmental impact of nanoscale materials, sincenanomedicinesmust be biocompatible for clinical application.

Related Conferences:

26th International Conference on Advanced Nanotechnology October 04-05 2018 Moscow, Russia; 18th International Conference and Exhibition on Nanomedicine and Nanotechnology in Health Care September 05-06, 2018 Auckland, Newzealand;International Conference and Exhibition on Pharmaceutical Nanotechnology and Nanomedicine April 18-19, 2018 Las Vegas, Nevada, USA; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology, April 09-11, 2018 Amsterdam, Netherlands; 19th International Conference onNanotechnology and Nanomedicine, July 9 – 10, 2017

Track 2:Design of Nanodrugs

To reach target cell, designing of nanodrugs are major aspects, where researcher interested for developing novel Nanodrugs.

Aimed and specially designed session for researchers developing Nanodrugs for delivery ofamino acids,Nucleic acidsand proteins. The session Design of Nanodrugs includes: Novel Drugs to Nano Drugs, Nanodrugs for Cancer Therapy, Nanodrugs for Veterinary Therapeutics, Nanodrugs for Medical applications and Nanodrugs forHerbal medicinesand Cosmetics.

Related conferences:

14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; International Conference and Exhibition on Pharmaceutical Nanotechnology and Nanomedicine April 18-19, 2018 Las Vegas, Nevada, USA; 4th International Conference and Expo on Drug Discovery, Designing & Development September 06-07, 2018 London, UK; International Conference on Biomedicine & Pharmacotherapy August 06-07, 2018 Osaka, Japan; 16th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Track 3:Nanomedicine and Nanotechnology

Nanotechnology for canceris a field that incorporates the studies related to nanosized particles, their function and behavior with respect to different systems. The tremendous capabilities of nanoparticles have changed the perspective and scope ofnanotechnologytowards development into an adjuvant field for the remaining fields of life sciences. The role of nanotechnology in the field of pharmaceutics has tremendously changed the way of our understanding about drugs, nanodrugs or the use of nanoparticles as carrier of drug has become the basic fundamental or criteria for the production or design of a drug andadvances in nanotechnology.

Nanotechnologyis an important field of modern research dealing with design, synthesis, and manipulation of particle structures ranging from approximately 1-100 nm.

The session Design of Nanomedicine and Nanotechnology includes broad topics like: Carbon Nanotubes,Nanoparticles, Gold Nanoparticles, Silver Nanoparticles, Magnetic Nanoparticles, Nano Micro Particles, Nanocomposite Microspheres, Biosensors and Nanobioelectronics, Bio inspired materials and drug delivery and Nanobiomechanics and Nanomedicine.

Related conferences:

Nanomaterials Conference,March 30-31, 2017, Madrid, Spain;MedicalNanotechnologySummitMay 22-23, 2017, Osaka, International Conference onPharmaceutics and Drug Delivery, March 13-15, 2017 London, UK; 2ndInternational Conference onNanomedicine, Drug Delivery, and Tissue Engineering, April 05-06, 2017, Barcelona, Spain; 19th International Conference onNanotechnology and Nanomedicine, July 9 – 10, 2017, Prague, Czech Republic; EuropeanNanomedicineMeeting 2017, April 3-4, 2017, London, UK; 19thInternational Conference onNanotechnology and Nanomedicine, June 21 – 22, 2017, Vienna, Austria; 4thWorld Congress and Expo onNanotechnology and Materials Science, April 05-07, 2017, Barcelona, Spain.Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine,Royal Society-NanoTechnology and NanoScience.

Track 4:Synthesis of Nanoparticles for Drug Delivery

Nanoparticles(NPs) have wide range of applications in areas such as health care, cosmetics, food and feed, environmental health, mechanics, optics, biomedical sciences, chemical industries, electronics, space industries, drug-gene delivery, energy science, optoelectronics, catalysis, single electron transistors, light emitters, nonlinear optical devices, and photo-electrochemical applications.

Synthesizing nanoparticles for pharmaceutical purposes such as drug preparation can be done in two methods. Bottom up process such as pyrolysis, inert gas condensation, solvothermal reaction, sol-gel fabrication and structured media in which hydrophobic compound such asliposomesare used as bases to mount the drug. Top down process such as attrition / milling in which the drug is chiseled down to form a nanoparticle

Nanocarriers, Gold Nanoparticles, Silver Nanoparticles, Liposomes, ligands,Nanoemulsions, Solid Lipid Nanoparticles, Polymeric Nanoparticles, Dendrimer Nanocarriers, Silica materials and Carbon Nanocarriers,nanotechnology and medicine.

Related conferences:

Nanomaterials ConferenceMarch 30- 31, 2017 Madrid,Spain;MedicalNanotechnologySummitMay 22-23, 2017 Osaka, Japan;Molecular Nanoscience MeetingOctober 20-22, 2016 Rome, Italy;Nanotechnology ExpoNovember 10-12 2016, Australia;Nanotech ExpoDecember 5-7 2016, USA; InternationalConference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; InternationalConference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic; InternationalConference on Biotechnology, Bioengineering andNanoengineering, April 14-15, 2016, Portugal; Meeting andExpo onNanomaterialsand Nanotechnology, 25th – 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece.Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 5:Regenerative Medicine and Tissue Engineering

The promise of regenerative medicine is truly remarkable.Regenerative medicineis a new branch of medicine that attempts to change the course of chronic disease, in many instances regenerating failing organ systems lost due to age, disease, damage, or congenital defects. The area is rapidly becoming one of the most promising treatment options for patients suffering from tissue failure.

TissueEngineering and Regenerative Medicine is appealing to scientists, physicians, and lay people alike: to heal tissue or organ defects that the current medical practice deems difficult or impossible to cure.

It covers numerous topics, such as stem cells, cell culture, polymer synthesis, novelbiomaterials, drug delivery, therapeutics, and the creation of tissues and organs.

This session dedicated to helping provide research-based solutions to issues related to human diseases and include with sessions as: tissue engineering, Organ fabrication, Tissue printing, Biomaterials, Biologic scaffolds, Hydrogels, Cell seeded matrices, Bioreactor design, Mechanical conditioning of engineered tissues, Mechanical properties of engineered tissues, Physiological properties of engineered tissues, Clinical outcomes of engineered tissue implantation, Cell-based therapies.

Related conferences:

Tissue Engineering and Regenerative Medicine ConferenceAug 20-22, 2017 Baltimore, USA;Stem Cell And Regenerative Medicine MeetingsMarch 20-22, 2017 Berlin, Germany; 8thWorld Congress on Stem Cell ResearchMarch 20-22, 2017 Orlando, USA; 5th InternationalConference onCell and Gene TherapyMay 19-21, 2016 San Antonio, USA; InternationalConference on Restorative MedicineOctober 24-26, 2016 Chicago, USA; InternationalConference on Molecular BiologyOctober 13-15, 2016 Dubai, UAE; 2nd InternationalConference on Tissue preservation and Biobanking September12-13, 2016 Philadelphia USA;Conference on Cardiac Development, Regeneration and RepairApril 3 7, 2016 Snowbird, Utah, USA; TheConference onStem Cell Development,May 22-26, 2016 Hillerd, Denmark;Conference onHematopoietic Stem Cells: June 3-5, 2016 Heidelberg, Germany;ISSCR Pluripotency ConferenceMarch 22-24, 2016 Kyoto, Japan ,Royal Society-NanoTechnology and NanoScience, International Association of Nanotechnology (IANT),American Association for the Advancement of Science , Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Track 6:Nanomedicine in Theranostics

Theranosticnanomedicineis emerging as a promising therapeutic paradigm. It takes advantage of the high capacity of nanoplatforms to ferry cargo and loads onto them bothimagingand therapeutic functions. The resulting nanosystems, capable of diagnosis,drug deliveryand monitoring oftherapeuticresponse, are expected to play a significant role in the dawning era ofpersonalized medicine, and much research effort has been devoted toward that goal.

Related Conferences:

Nanomaterials ConferenceMarch 30- 31, 2017 Madrid,Spain;MedicalNanotechnologySummitMay 22-23, 2017 Osaka, Japan;Molecular Nanoscience MeetingOctober 20-22, 2016 Rome, Italy;Nanotechnology ExpoNovember 10-12 2016, Australia;Nanotech ExpoDecember 5-7 2016, USA; InternationalConference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; InternationalConference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic; InternationalConference on Biotechnology, Bioengineering andNanoengineering, April 14-15, 2016, Portugal; Meeting andExpo onNanomaterialsand Nanotechnology, 25th – 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece.Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 7:Nanomedicines and Biomedical Applications

Nanomedicineseeks to deliver a valuable set of research tools and clinically useful devices. The pharmaceutical industry is developing new commercial applications that may include advanced drug delivery systems, new therapies, andNanomaterials for Imaging and Drug Delivery. Another active and very much related area of research is the investigation of toxicity and environmental impact of nanoscale materials, sincenanomedicinesmust be biocompatible for clinical application.

Related Conferences:

Nanomaterials ConferenceMarch 30- 31, 2017 Madrid,Spain;MedicalNanotechnologySummitMay 22-23, 2017 Osaka, Japan;Molecular Nanoscience MeetingOctober 20-22, 2016 Rome, Italy;Nanotechnology ExpoNovember 10-12 2016, Australia;Nanotech ExpoDecember 5-7 2016, USA; InternationalConference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; InternationalConference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic; InternationalConference on Biotechnology, Bioengineering andNanoengineering, April 14-15, 2016, Portugal; Meeting andExpo onNanomaterialsand Nanotechnology, 25th – 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece.Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 8:Drug Delivery Research

Drug Delivery Conferences attains greater global significance asDrug Deliveryplays a significant role in the future of pharmaceutical research Novel drug delivery system method by which a drug is delivered can have a significant effect on its efficacy. Conference includes topics likelipid Polymersto enhance drug delivery technology by providing controlled release of therapeutic agents in constant doses over long periods, cyclic dosage, and tunable release of both hydrophilic and hydrophobic drugs.In vitro & in vivodissolution testing is required to ensure that drug dissolves at a consistent rate from batch to batch of formulated drug product. Improvement of dissolution rate of poorly soluble drugs can be increased by dissolving them in liquid hydrophilic vehicles followed by soaking on highly porous materials. The major part is to deliver an innovative speech on the latestTargeted drug deliveryis a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others.Pharmacokineticbehavior indrug designanddrug developmentfor safety issues arising either as a result of animal toxicity testing or in the clinical program itself

Related Conferences:

10thPharmaceutics and Novel Drug Delivery Systems Conference, March 13-15, 2017 London, UK; 6thAnnual Conferences onEuropean Pharma Congress, July 10-12, 2017 Madrid, Spain; 3ndInternationalConference on BiopharmaceuticsJune 22-23, 2017 Baltimore, USA; 3ndInternationalConference on Biologic Drugs, June 22-23, 2017 Baltimore, USA; 6rdWorldCongress on PharmacologyAugust 7-9, 2017 Paris, France; 2ndInternationalConference on Parenterals, December 05-07, 2016 Texas, USA; 2ndInternationalConference on InjectablesDecember 05-07, 2016, Texas, USA;Respiratory Drug Delivery Conference, April 25-28, 2017 France;Drug Delivery Partnership, February 7-9, 2017 Florida USA; 6thInternationalConference on Drug Formulation, 6thInternational Conference on SolubilityMarch 20-22, 2017 Philadelphia, USA, 6th International Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA;Congress on Innovation in Drug Delivery(APGI),Controlled Release Society(CRS),International Society for Aerosols in Medicine(ISAM),The Pharmaceutical and Healthcare Sciences Society(PHSS),Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 9:Novel Drug Delivery Systems

To maximize knowledge of the current researcher on developingdrug delivery systemsvia Novel techniques forPharmaceutical formulationdevelopment, Drug Delivery conference themed quality topics onLiposomes, Dendrimer,Targeted Drug Deliverydesign, versatile polymer in Drug Delivery andControlled Drug Delivery, Trans mucosal Drug Delivery, Blood Brain Barrier, Optimization of pharmaceutical products, SustainedDrug Delivery Systems, are a uniquely architect session to play an important role in the fields of pharmaceutical formulation development andPharmacology.

Related Conferences:

10thPharmaceutics and Novel Drug Delivery Systems Conference, March 13-15, 2017 London, UK; 6thAnnual Conferences onEuropean Pharma Congress, July 10-12, 2017 Madrid, Spain; 3ndInternationalConference on BiopharmaceuticsJune 22-23, 2017 Baltimore, USA; 3ndInternationalConference on Biologic Drugs, June 22-23, 2017 Baltimore, USA; 6rdWorldCongress on PharmacologyAugust 7-9, 2017 Paris, France; 2ndInternationalConference on Parenterals, December 05-07, 2016 Texas, USA; 2ndInternationalConference on InjectablesDecember 05-07, 2016, Texas, USA;Respiratory Drug Delivery Conference, April 25-28, 2017 France;Drug Delivery Partnership, February 7-9, 2017 Florida USA; 6thInternationalConference on Drug Formulation, 6thInternational Conference on SolubilityMarch 20-22, 2017 Philadelphia, USA, 6th International Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA;Congress on Innovation in Drug Delivery(APGI),Controlled Release Society(CRS),International Society for Aerosols in Medicine(ISAM),The Pharmaceutical and Healthcare Sciences Society(PHSS),Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 10:Smart Drug Delivery Technology

To maximize knowledge of the current researcher on developingdrug deliveryviaPharmaceutical formulation, Smart Drug Delivery conference themed quality topics onDrug Targeting,Drug Designing,Drug evaluation,Drug Delivery and Therapeutics, Biodegradable polymers, Dendrimer a versatile polymer in drug delivery are a uniquely architect session to play an important role in the fields of nanotechnology, pharmaceutical and medicinal chemistry.

Major drugs driving growth of the overall smart drug delivery market include Angiomax, Copaxone, Forteo, Sandostatin, Velcade, Victoza and Zoladex

Related Conferences:

10thPharmaceutics and Novel Drug Delivery Systems Conference, March 13-15, 2017 London, UK; 6thAnnual Conferences onEuropean Pharma Congress, July 10-12, 2017 Madrid, Spain; 3rdInternationalConference on BiopharmaceuticsJune 22-23, 2017 Baltimore, USA; 3rdInternationalConference on Biologic Drugs, June 22-23, 2017 Baltimore, USA; 6rdWorldCongress on PharmacologyAugust 7-9, 2017 Paris, France; 2ndInternationalConference on Parenterals, December 05-07, 2016 Texas, USA; 2ndInternationalConference on InjectablesDecember 05-07, 2016, Texas, USA;Respiratory Drug Delivery Conference, April 25-28, 2017 France;Drug Delivery Partnership, February 7-9, 2017 Florida USA; 6thInternationalConference on Drug Formulation, 6thInternational Conference on SolubilityMarch 20-22, 2017 Philadelphia, USA, 6th International Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA;Congress on Innovation in Drug Delivery(APGI),Controlled Release Society(CRS),International Society for Aerosols in Medicine(ISAM),The Pharmaceutical and Healthcare Sciences Society(PHSS),Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 11:Nano Pharmaceuticals

Pharmaceutical NanotechnologyforDrug Delivery using Nanotechnologysession plays major role in the future of pharmaceutical research. In this session, we will go over several of the most important features of nanotechnology,anticancer drug development,pharmocology of cancer drugs, that will impact our lives but we will also talk about what nanotechnology itself will be like in the future and Investigator specifically from cancer therapy. Interestinglypharmaceutical sciencesare usingnanoparticlesto reduce toxicity and side effects of drugs and up to recently did not realize that carrier systems themselves may impose risks to the patient.

Nano technology session includesdrug delivery using nanotechnology,Pharmaceutical technology, Nanoparticles permeability to BBB,Cancer drug targets, Nanoparticles application,Pancreatic Cancer, Nanoliposome-mediated delivery, MicroRNA therapeutics, recent breakthroughs in nanoparticle design to demonstrate their high potential as multifunctional drug delivery nanocarrier, Carriers for nanotechnology, various nanostructures, magnetic nanoparticles. In this reviewPolymer Nanotechnologyfor Drug Delivery,Nano compositematerials, to deliver highly efficient therapeutic compounds to patient a future aspect of Nanotechnology has a vast future ahead of it and we are constantly making breakthroughs in this industry every day.

Related Conferences:

20thInternationalConference on Nanoscience, Dec 19-20, 2017 Osaka, Japan 11thInternationalConference on Molecular Nanotechnology, October 20-22, 2016 Rome, Italy, UK; InternationalConference on Nano medicine, July 24-25, 2017 Melbourne, Australia;Conference on Nanotechnologyin Health Care , July 24-25, 2017 Melbourne, Australia; 3rdInternationalConference on BiopharmaceuticsJune 22-23, 2017 Baltimore, USA; 3rdInternationalConference on Biologic Drugs, June 22-23, 2017 Baltimore, USA; 6rdWorldCongress on PharmacologyAugust 7-9, 2017 Paris, France; 2ndInternationalConference on Parenterals, December 05-07, 2016 Texas, USA; 2ndInternationalConference on InjectablesDecember 05-07, 2016, Texas, USA;Respiratory Drug Delivery Conference, April 25-28, 2017 France;Drug Delivery Partnership, February 7-9, 2017 Florida USA; 6thInternationalConference on Drug Formulation, 6thInternational Conference on SolubilityMarch 20-22, 2017 Philadelphia, USA, 6th International Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA;Congress on Innovation in Drug Delivery(APGI),Controlled Release Society(CRS),International Society for Aerosols in Medicine(ISAM),The Pharmaceutical and Healthcare Sciences Society(PHSS),Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 12:Biopharmaceutics and Biologic Drugs

Biopharmaceutics is defined as the study of factors influencing the rate and amount of drug that reaches the systemic circulation and the use of this information to optimise the therapeutic efficacy of the drug products. The process of movement of drug from its site of administration to the systemic circulation is called as absorption. The concentration of drug in plasma and hence the onset of action, and the intensity and duration of response depend upon the bioavailability of drug from its dosage form. Bioavailability is defined as the rate and extent (amount) of drug absorption.Biologic Drugs, or biologic response modifiers, are medications genetically engineered from a living organism, such as a virus, gene or protein, to simulate the bodys natural response to infection and disease. Biologics target proteins, cells and pathways responsible for the symptoms and damage of rheumatoid arthritis and other types of inflammatory arthritis. Biologic response modifiers (biologics for short) are drugs that are genetically engineered from a living organism, such as a virus, gene or protein, to simulate the bodys natural response to infection and disease.

Related conference:

13th International Conference on Biopharma and BiotherapeuticsOctober 24-25, 2018 Boston, Massachusetts, USA ,Global Summit on Biopharma and BiotherapeuticsMontreal, Canada May 14-15, 2018,International Conference on Nano Medicine and NanoparticlesApril 18-19, 2018 Las Vegas, USA11th European Biosimilars CongressApril 26-27, 2018 Rome, Italy

Track 13:Nano Biotechnology

Nanobiotechnologyis the intersection of nanotechnology and biology.Nanobiotechnologyhas multitude of potentials for advancing medical science thereby improving health care practices around the world. Nanomedicine is used to treat diseases bygene therapy. Nano biotechnologies are being applied to molecular diagnostics and several technologies are in development.

Related Conferences:

Nanomaterials ConferenceMarch 30- 31, 2017 Madrid,Spain;MedicalNanotechnologySummitMay 22-23, 2017 Osaka, Japan;Molecular Nanoscience MeetingOctober 20-22, 2016 Rome, Italy;Nanotechnology ExpoNovember 10-12 2016, Australia;Nanotech ExpoDecember 5-7 2016, USA; InternationalConference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; InternationalConference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic; InternationalConference on Biotechnology, Bioengineering andNanoengineering, April 14-15, 2016, Portugal; Meeting andExpo onNanomaterialsand Nanotechnology, 25th – 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece.Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 14:Nano Pharmaceutical Industry and Market

Nano Pharmaceutical IndustryCompanies and Market session is beginning to change for small, medium, and large scale pharmaceutical Co,biopharmaceutical Manufacturing and Industries, generic drugscompanies,contract drug delivery companieswhich can manifest from development to manufacturing. Addressing these instabilities is a great challenge, because of the complexity of theClinical bio therapeuticsthemselves. This session includes Rheological behavior,Pharmaceutical Guidelines,Pharmaceutical companies and regulatory guidelinesperspectives, Advances in computational modeling forbioavailability,drug Stabilityof Pharmaceutical products which are driving crucial research into new vaccines and medicines. The pharmaceutical industry and the public sector are thinking differently than before about how to improve access to medicines and advance research and development for neglected diseases.

Related Conferences:

International Conference onPharma Marketing Conference, November 17-19, 2016 Alicante, Spain; 4th Annual conferences onEuropean Pharma Congress, June 13-15, 2016 Berlin, Germany; 2ndInternationalConference on Biologic Drugs, September 15-17, 2016 San Antonio, USA; 3rdWorldCongress on PharmacologyAugust 08-10, 2016 Birmingham, UK; 2ndInternationalConference on Parenterals, December 05-07, 2016 Dallas, Texas, USA; 2ndInternationalConference on InjectablesDecember 05-07, 2016 Dallas, Texas, USA;Respiratory Drug Delivery Conference, April 25-28, 2017 France;Drug Delivery Partnership, February 7-9, 2017 Florida USA; 6thInternationalConference on Drug Formulation, 6thInternational Conference on SolubilityMarch 20-22, 2017 Philadelphia, USA, 6th International Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA;Congress on Innovation in Drug Delivery(APGI),Controlled Release Society(CRS),International Society for Aerosols in Medicine(ISAM),The Pharmaceutical and Healthcare Sciences Society(PHSS),Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Track 15:Regulatory Aspects Towards Approval of Nanomedicine

Nanoethicsis the study ethical and social implications of nanotechnologys. It is an emerging but controversial field.Nanoethics is a debatable field.As the research is increasing on nanomedicine, there are certain regulations to increase their efficacy and address the associated safety issues. Other issues in nanoethics include areas likeresearch ethics, environment,global equity, economics, politics, national security, education, life extension and space exploration.

Related Conferences:

Nanomaterials ConferenceMarch 30- 31, 2017 Madrid,Spain;MedicalNanotechnologySummitMay 22-23, 2017 Osaka, Japan;Molecular Nanoscience MeetingOctober 20-22, 2016 Rome, Italy;Nanotechnology ExpoNovember 10-12 2016, Australia;Nanotech ExpoDecember 5-7 2016, USA; InternationalConference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; InternationalConference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic; InternationalConference on Biotechnology, Bioengineering andNanoengineering, April 14-15, 2016, Portugal; Meeting andExpo onNanomaterialsand Nanotechnology, 25th – 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece.Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nanomedicine.

Summary of Nanodelivery 2018 Conference:

Nano Delivery 2018is an emerging field of engineering andlife sciencesthat promises to revolutionizemedicineand medical technology. There are numerous applications ofnanomedicineandDrug Delivery using Nanotechnologyin medicinal diagnostics. These include improvedimaginingof the human (or any) body and detectingtumorsthat are only a few cells in size.

The idea thatpharmaceutical agentsshould be delivered specifically to diseased cells holds the promise of a variety of benefits. The promise of individualized medicine is that it is efficient.Targeted drug-deliveryallows doctors and patients to benefit from small dosages at just the right place and thus from fewer side effects.

Nanomedicine hastherapeuticuses as well. Nanotechnology is capable of delivering medication to the exact location where they are needed, hence lesser side effects. It can also be used to destroy harmful organisms orcancer cellsby interrupting their division process. Nanoprobes can be made to generate radiation that could kill bacteria, viruses and cancer cells. Nanotechnology also theoretically allows the mimicking of natural biological processes, e.g. repair of damaged tissues or acting as artificial red blood cells to transport oxygen.

The global market forhealthcare nanotechnologyis expected to reach USD 196.02 billion by 2020 growing at a CAGR of 12.1%, according to a new study by Grand View Research, Inc. Increasing susceptibility of patients towards chronic diseases such as cardiovascular, neurological, oncology and respiratory diseases coupled with increasing R&D spending opening new application avenues is expected to drive market growth over the next six years. Other drivers of this market include increasing government and private sector R&D aid and new players entering the market to bridge the gap between supply and demand.

Importance & Scope of Nano Delivery:

Read the original post:
Top Nanomedicine Conferences|DrugDelivery meetings …

Recommendation and review posted by Alexandra Lee Anderson

Journal of Nanomedicine & Nanotechnology – Open Access Journals

NLM ID : 101562615SJR H Index:13, Google Scholar h5-index: 13ICDS = 3.8ICV Value: 101.22

Nanomedicine is the application of nanotechnology which made its debut with greatly increased possibilities in the field of medicine. Nanomedicine desires to deliver research tools and clinically reformative devices in the near future.

Journal of Nanomedicine & Nanotechnology covers wide varieties of topics such as molecular nanotechnology, nanosensors, nanoparticles, nanodrugs, Nanomaterials, nanobiotechnology, nanobiopharmaceutics, nanoelectronics, nanorobotics, etc.. The journal includes a wide range of fields in its discipline to create a platform for the authors to make their contribution towards the journal and the editorial office promises a peer review process for the submitted manuscripts for the quality of publishing.

The journal is using Editorial Manager System for quality peer review process. Editorial Manager is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of Journal of Nanomedicine & Nanotechnology or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.

The Journal of Nanomedicine & Nanotechnology is a scientific journal which provides an opportunity to share the information among the medical scientists and researchers. The main function of open access publishing platforms is to present the content online, making it available to all, and link this information with useful scientific data.The Journal of Nanomedicine & Nanotechnology aims to publish articles bimonthly and is one of the best open access journals of scholarly publishing.

Journal of Nanomedicine & Nanotechnology is anacademic journal which aims to publish most complete and reliable source of information on the discoveries and current developments in the mode of Research articles, Review articles, Case reports, Short communications, etc. in all areas of the field and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide.

You can find a clear view of peer review process by clicking here.

Material Science Research: Material Science and NanotechnoMaterials are crucial to the performance and reliability of virtually every technology and the vitality and health of any living organism. The central theme of materials science and engineering is that the process by which a material comes into being determines its structure, which in turn controls its properties and ultimately its functional performance.

Nanotechnology is the engineering of functional systems at the molecular scale. It is the study and application of extremely small things and can be used across all the other science fields, such as chemistry, biology, physics, materials science, and engineering.

Related Journals of NanotechnologyNanoscience and Nanotechnology, Nanoscience and Nanotechnology Letters, Journal of Nanomedicine & Biotherapeutic Discovery, IEEE Transactions on Nanobioscience, Journal of Biomedical Nanotechnology, Photonics and Nanostructures – Fundamentals and Applications

Nanobiotechnology is the application of nanotechnology to the life sciences: The technology encompasses precision engineering as well as electronics, and electromechanical systems as well as mainstream biomedical applications in areas as diverse as gene therapy, drug delivery and novel drug discovery techniques.

Related Journals of NanobiotechnologyJournal of Biomedical Nanotechnology, Research Journal of Nanoscience and nanotechnology, Nature Nanotechnology Journal, Nanomaterials & Molecular Nanotechnology, Nature Nanotechnology, Nano Letters, Advanced Materials, Nano Today

A Nanocomposite is a multiphase solid material where one of the phases has one, two or three dimensions of less than 100nm, or structure having nano-scale repeat distance between the different phases that make up the material.

Related Journals of Nanocomposites

Journal of Nanomaterial and Nanotechnology, International Journal of Nanotechnology Impact Factor, Journal of Nanomedicine & Biotherapeutic Discovery, Scripta Materialia, Nanoscale, Lab on a Chip – Miniaturisation for Chemistry and Biology, Materials Science & Engineering A: Structural Materials: Properties, Microstructure and Processing

The Integrated Project Nanobiopharmaceutics aims at the development of innovative multidisciplinary approaches for the design, synthesis and evaluation of functionalised nano-carriers and nano-particle-based micro-carriers for the treatment of various diseases based on targeted, controlled delivery of therapeutic peptides and proteins (biopharmaceutics).

Related Journals of NanobiopharmaceuticsJournal of Nanomedicine & Biotherapeutic Discovery, Journal of Nanobiomedical Impact Factor, Journal of Obsessive-Compulsive and Related Disorders, Journal of Homotopy and Related Structures, Journal of Venomous Animals and Toxins including Tropical Diseases

Nanoelectronics is one of the major technologies of Nanotechnology. It plays vital role in the field of engineering and electronics.

Related Journals of Nanoelectronics Journal of Nanotechnology and Electrophysics, Nano Research & Applications, ACS Applied Materials and Interfaces, International Journal of Nanotechnology Applications, Biosensors and Bioelectronics, Journal of Physical Chemistry C, Nanomedicine: Nanotechnology, Biology, and Medicine

Nanomedicine is the medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology.

Related Journals of Nanomedicine Nanomaterials & Molecular Nanotechnology, Pharmaceutical Nanotechnology, Journal of Biomedical Nanotechnology, International Journal of Nanomedicine, Nanomedicine: Nanotechnology, Biology and Medicine, Journal of Nanomedicine Research, European Journal of Nanomedicine

Nanotoxicology is a branch of toxicology concerned with the study of the toxicity of nanomaterials, which can be divided into those derived from combustion processes (like diesel soot), manufacturing processes (such as spray drying or grinding) and naturally occurring processes (such as volcanic eruptions or atmospheric reactions).

Related Journals of NanotoxicologyNanomedicine & Nanotechnology, Nanotechnology Journal Lists, Nano Journal Impact Factor, Microscale Thermophysical Engineering, Microelectronic Engineering, Nano Biomedicine and Engineering, Nano-Micro Letters

Nanoengineering is the practice of engineering on the nanoscale. It derives its name from the nanometre, a unit of measurement equalling one billionth of a meter. Nanoengineering is largely a synonym for nanotechnology, but emphasizes the engineering rather than the pure science aspects of the field.

Related Journals of NanoengineeringJournal of Nanoresearch, Review in Nanoscience and Nanotechnology, Nature Nanotechnology Journal, Research & Reviews: Journal of Pharmaceutics and Nanotechnology, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, Nanotoxicology, Precision Engineering, Nanomedicine, Nanotechnology

The spontaneous association of molecules under equilibrium conditions into stable, structurally well-defined aggregates.

Related Journals of NanofabricationsJournal of Nanotechnology Impact Factor, Nanotechnology Journal Lists, Journal of Nano, Nanomaterials & Molecular Nanotechnology, Microporous and Mesoporous Materials, International Journal of Nanomedicine, Beilstein Journal of Nanotechnology

Nanofluidics is often defined as the study and application of fluid flow in and around nanosized objects.

Related Journals of Nanofluidics Research Journal of Nanoscience and Nanotechnology, Nano Journal Impact Factor, Journal of Nanotechnology and Electrophysics, Journal of Bionanoscience, Nanotechnology, Science and Applications, Journal of Nanobiotechnology, Plasmonics, Biomedical Microdevices

Nanohedron aims to exhibit scientific images, with a focus on images depicting nanoscale objects. The work ranges from electron microscopy images of nanoscale materials to graphical renderings of molecules. Scientific images lying outside the realm of nanoscience such as algorithmic art or confocal microscopy images of cells will also be considered.

Related Journals of Nanohedron Biomicrofluidics, Nanotechnology Journal Lists, Nano Journal Impact Factor, IEEE Transactions on Nanotechnology, Microfluidics and Nanofluidics, Journal of Micromechanics and Microengineering

Nano Cars Into the robotics is new technology which is useful for designing robots. Difference in exisiting robotics and nano cars is this system works as nervous system where as in existing system stepper motors are used.

Related Journals of Nanocars Pharmaceutical Nanotechnology, Journal of Nanobiomedical Impact Factor, Review in Nanoscience and Nanotechnology,Nanomedicine & Biotherapeutic Discovery, ACS Nano, Advanced Functional Materials, Journal of Physical Chemistry Letters, Biomaterials, Small, Nano Research

Nanothermite, as the name suggests, is thermite in which the particles are so small that they are measured in nanometers is an ultra-fine-grained (UFG) variant of thermite that can be formulated to be explosive by adding gas-releasing substances.

Related Journals of NanothermiteNanoscale Research Letters, Journal of Nanobiomedical Impact Factor, International Journal of Nanoscience, Microelectronics and Reliability, Journal of Nanoparticle Research, AIP Advances

A sequence of nanoscale C60 atoms arranged in a long thin cylindrical structure. Nanotubes are extremely strong mechanically and very pure conductors of electric current. Applications of the nanotube in nanotechnology include resistors, capacitors, inductors, diodes and transistors.

Related Journals of NanotubesNanotechnology journals, Nature Nanotechnology Journal, Nano Journal Impact Factor, ACM Journal on Emerging Technologies in Computing Systems, Science of Advanced Materials, Journal of Nanophotonics

Having an organization more complex than that of a molecule.

Realated Journals of Supramolecule Plasmonics, Journal of Biomedical Nanotechnology, International Journal of Nanoscience, Journal of Nanobiomedical Impact Factor, Biomedical Microdevices, Biomicrofluidics, IEEE Transactions on Nanotechnology

Nanoionics is the study and application of phenomena, properties, effects and mechanisms of processes connected with fast ion transport (FIT) in all-solid-state nanoscale systems.

Related Journals of Nanoionics Journal of Nanoresearch, Journal of Nanoscience and Nanotechnology, Journal of Biomedical Nanotechnology, Nanomedicine, Nanotechnology, Microporous and Mesoporous Materials, International Journal of Nanomedicine

Nanolithography is the branch of nanotechnology concerned with the study and application of fabricating nanometer-scale structures, meaning patterns with at least one lateral dimension between 1 and 100 nm.

Related Journals of NanolithographyInternational Journal of Nanotechnology, Journal of Nanotechnology Impact Factor, Nanoscience and Nanotechnology Letters, Nano Research, Scripta Materialia, Nanoscale, Lab on a Chip – Miniaturisation for Chemistry and Biology

Nanoparticles are particles between 1 and 100 nanometers in size. In nanotechnology, a particle is defined as a small object that behaves as a whole unit with respect to its transport and properties. Particles are further classified according to diameter.

Related Journals of Nanoparticles Journal of Nanoscience and Nanotechnology, International Journal of Nanoscience, Journal of Nanomaterial and Nanotechnology, Journal of Nanoparticle Research, Journal of Nanoparticles, International Journal of Nanoparticles,

Exploitation of biomaterials, devices or methodologies on the nanoscale.

Related Journals of Bionanoscience Pharmaceutical Nanotechnology, Journal of Nanobiomedical Impact Factor, Journal of Biomedical Nanotechnology, Recent Patents in Nanotechnology, Journal of Bionanoscience, BioNanoScience, Nanomedicine, Nanotechnology, Microporous and Mesoporous Materials

Read the original post:
Journal of Nanomedicine & Nanotechnology – Open Access Journals

Recommendation and review posted by Alexandra Lee Anderson

Top Nanotechnology Conferences | Top Nanomedicine …

Sessions/Tracks

Pharma Nano 2018-USA is a global annual event. This Pharma Nano 2018-USA brings together scientists, researchers, business development managers, CEOs, directors, IP Attorneys, Regulatory Officials and CROs from around the world. The passage of approval for Nano Medicine finds much requirement for discussion also focussing the latest developments in the field of Nano Medicine and Nanoparticles

Theme: Breakthroughs in Pharmaceutical Nanotechnology: Advancements and Challenges.

Track 1: Nanoparticles and Nanomedicine

Nanomedicineis a branch of medicine that applies the knowledge and tools of nanotechnology in the prevention and treatment of diseases. Nanomedicine involves the use of nanoscale materials, such as biocompatible nanoparticles and nano robots, for diagnosis, delivery, sensing or actuation purposes in a living organism. Nanoparticles from 1-100 nm have been widely used to improve the drug accumulation, internalization and therapeutic efficacy. The physicochemical and biological properties of the nanoparticles can also be finely adjusted by tailoring their chemical properties, sizes, shapes, structures, morphologies, and surface properties. Nanomedicine is the medical application of nanotechnology. Nanotechnology has provided the possibility of delivering drugs to specific cells using nanoparticles. Current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials.

Track 2: The Evolution of Nanomedicine with the Re-Evolution of Nanotechnology

Nanotechnology seems to have gained a widespread interest in the recent years. Nanotechnology has considerably accelerated the growth of regenerative medicine in the past few years. Application of nanotechnology in regenerative medicine has revolutionized the designing of grafts and scaffolds which has resulted in new grafts/scaffold systems having significantly enhanced cellular and tissue regenerative properties. Since the cellcell and cell-matrix interaction in biological systems takes place at the nanoscale level, the application of nanotechnology gives an edge in modifying the cellular function and/or matrix function in a more desired way to mimic the native tissue/organ. Nanomedicine introduces nanotechnology concepts into medicine and thus joins two large cross disciplinary fields with an unprecedented societal and economical potential arising from the natural combination of specific achievements in the respective fields.

Track 3: Computational Studies in Nanoparticles

The computational studies in nanoparticles have demonstrated that there has been considerable progress in nano- and biotechnologyinthe last several years. However, several key challenges have also become apparent, including the need for a better understanding of nanoparticle behaviour in vivo and the development of more effective nanoparticle therapeutics. Computational efforts are becoming an important tool in addressing both of these challenges, as well as in generally facilitating and accelerating nanotechnology-based translational research. The nanoinformatics has comes out as a new research area that covers raw data management, analysis of the data derived from biomedical applications and simulation of nanoparticle interactions with biological systems depicting the integration of biology, nanotechnology and informatics to form the basis for computational nanomedicine.

Track 4: Toxicology of Nanoparticles

Nanotechnology is a rapidly growing field having potential applications in many areas. Nanoparticles have been studied for cell toxicity, immunotoxicity, and genotoxicity. Tetrazolium-based assays such as MTT, MTS, and WST-1 are used to determine cell viability. Different types of cell cultures, including cancer cell lines have been employed as in vitro toxicity models. Considering the potential applications of NPs in many fields and the growing apprehensions of FDA about the toxic potential of nanoproducts, it is the need of the hour to look for new internationally agreed free of bias toxicological models by focusing more on in vivo studies. The rapid expansion of nanotechnology promises to have great benefits for society, yet there is increasing concern that human and environmental exposure to engineered nanomaterials may result in significant adverse effects. The system was developed for nanotoxicity assessment at single and multiple cell levels which can measure and compare the microscopic and macroscopic effects of nanoparticles interaction with cells, without interference from neighbour ing cells’ cues and also overall integrative effects produced by nanoparticles and cellcell communication.

Track 5: Emerging Nanomedicine

Currently, the treatment of HIV requires daily regular oral dosage of HIV drugs, and chronic oral dosing has significant complications that arise from the high pill burden experienced by many patients across populations with varying conditions leading to non-adherence to therapies. Recent evaluation of HIV patient groups have shown a willingness to switch to nanomedicine alternatives if benefits can be shown. Research efforts by the Liverpool team have focused on the development of new oral therapies, using Solid Drug Nanoparticle (SDN) technology which can improve drug absorption into the body, reducing both the dose and the cost per dose and enabling existing healthcare budgets to treat more patients.

In a four-year study conducted on the mouse model in advanced breast cancer metastasis in the eye’s anterior chamber, the new nanoparticle not only killed tumour cells in the eye, but also extended the survival of experimental mice bearing 4T1 tumors, a cell line that is extremely difficult to kill. “Previous monotherapies have not extended the lifetimes of mice bearing this type of tumour”.

Track 6: Smart Drug Delivery Technology

Some smart drug delivery platform is based on neutral phospholipid nanoliposomes. Classic liposomes modalities have had manufacturing problems involving sizing, uniformity, loading, storage, and enhancement compatibility, which can be overcome by employing true nanotechnology to build liposomes upon discrete self-assembling DNA scaffolds. The smart drug delivery system is used for delivering drugs to the host. Biological information detected by biological sensors is analyzed and the drug delivery system is actuated to deliver the drug based on the information. MEMS or NEMS technology based drug pumps, micro-pumps, micro-needles, micro-osmotic pumps, and nano-pumps are utilized for smarter drug delivery. One of the concerns these days about self-assembling nanotechnology is that it is so advanced beyond the current drug paradigm that it becomes problematic from a regulatory point of view. While there is currently no drug treatment delivered directly into these types of cancers.

Track 7: Design and Characterization of Nano Drug Systems

Recent years have witnessed the rapid development of inorganic nanomaterials for medical applications. At present, nanomedicines-nanoparticles (NPs) destined for therapy or diagnosis purposes-can be found in a number of medical applications, including therapeutics and diagnosis agents. Pushing the limits of nanotechnology towards enhanced nanomedicines will surely help to reduce side effects of traditional treatments and to achieve earlier diagnosis. The interplay between engineered nanomaterials and biological components is influenced by complex interactions which make predicting their biological fate and performance a nontrivial issue. We hope that both early-stage and experienced researchers will find it valuable for designing nanoparticles for enhanced bio-performance. Nanoemulsions have attracted great attention in research, dosage form design and pharmacotherapy. This is as a result of a number of attributes peculiar to nanoemulsions.

Track 8: Nanoparticles as Precise Drug Delivery Systems

With the remarkable development of nanotechnology in recent years, new drug delivery approaches based on the state-of-the-art nanotechnology have been receiving significant attention. Nanoparticles, an evolvement of nanotechnology, are increasingly considered as a potential candidate to carry therapeutic agents safely into a targeted compartment in an organ, particular tissue or cell. These particles are colloidal structures with a diameter less than 1,000 nm, and therefore can penetrate through diminutive capillaries into the cells internal machinery. This innovative delivery technique might be a promising technology to meet the current challenges in drug delivery. The different types of nanoparticles drug delivery systems under investigation and their prospective therapeutic applications, and also present a closer look at the advances, current challenges, and future direction of nanoparticles drug delivery systems.

Track 9: Polymer Nanoparticles for Nanomedicines

The use of nanoscale materials and processes to address human diseases is perhaps the most promising, considering that most complex downstream symptoms of disease are initiated by molecular level phenomena. Nanomedicine is defined as biological and medical intervention at the nanometer scale for the treatment, diagnosis, and increased understanding of biology and disease. Tremendous advances in the area of polymer synthesis and self-assembly have given rise to a new toolbox of engineered nanosized delivery and diagnostic agents that permit systemic and local administration, circulation in the bloodstream, and uptake and diffusion at the cellular and subcellular level.

Track 10: Nano Medicine Industry and Market Analysis

Nano Medicine Industry and Market Analysis focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and the rest of the world the report is a valuable asset for the existing players, new entrants and the future investors. The study The Global Nanomedicine Market is poised to grow at a CAGR of around 16.6% over the next decade to reach approximately $1.3 trillion by 2025.This industry report analyses the global markets for Nanomedicine across all the given segments on global as well as regional levels presented in the research scope.

Track 11: Research and Development of Nanomedicine

Nanomedicine has been developing rapidly in recent years, particularly in the development of novel nano tools for medical diagnosis and treatment. For instance, a new trend is becoming prevalent in developing nanosystems for simultaneous tumour diagnosis and therapy. A new terminology “theranostics” has been frequently used and applied in pre-clinical research and trials. A nanosystem can simultaneously achieve both cell targeted during in vivo imaging and photothermal treatment of cancer. While achieving concurrent high spatial and temporal resolution of the lesions via cell targeting; special non-evasive treatments are implemented at the same time by various means, such as localized drug release, hyperthermia, and photo-thermal therapy. Inspired by these challenging problems in biomedical fields, the development of the nanotechnologies will be the key in addressing some of the critical issues in medicine, especially in early cancer diagnosis and treatment.

Track 12: Nano Pharmaceutical Medicine

The term Nano became tantamount to cutting-edge and was quickly embraced by the pharmaceutical science community. The novel concept of nanomedicinegenerated as a result of a scientific amalgamation between nanoscience and nanotechnology with medicine. Pharmaceutical scientists quickly adopted nanoscience terminology, thus creating Nano pharmaceuticals. Moreover, just using the term nano intuitively implied state-of-the-art research and became very fashionable within the pharmaceutical science community. Formulation of Nano pharmaceuticals contain active extracts obtained from medicinal plants. In physiological conditions, the interactions between blood platelets and endothelial cells play a major role in vascular reactivity and haemostasis. In contrast, increased platelet activation contributes to the pathogenesis of vascular pathology such as atherosclerosis, thrombosis, diabetes mellitus, hypertension and carcinogenesis. The rapid developments in nanostructured materials and nanotechnology will have profound impact in many areas of biomedical applications including delivery of drugs and biomolecules, tissue engineering, detection of biomarkers, cancer diagnosis, cancer therapy and imaging.

Track 13: Nanoparticle Interaction

Particleparticle interactions in physiological media are important determinants for nanoparticle fate and transport. Herein, such interactions are assessed by a novel atomic force microscopy -based platform. Industry-relevant CeO2, Fe2O3, and SiO2 nanoparticles of various diameters were made by the flame spray pyrolysis (FSP)-based Harvard Versatile Engineering Nanomaterials Generation System (Harvard VENGES). The nanoparticles were fully characterized both structurally and morphologically, and their properties in water and biological media were also assessed. The nanoparticles were attached on AFM tips and deposited on Si substrates to measure particleparticle interactions. Nanoparticle interactions in solution affect their binding to biomolecules, their electronic properties, and their packing into larger crystals. However, the theories that describe larger colloidal particles fail for nanoparticles, because the interactions do not add together linearly. Nanoparticle interactions are often described by classical colloidal theories developed for Ps.

Track 14: Nanomedicine Ethical Issues

As the science and technology of nanomedicine speed ahead, ethics, policy, and the law struggle to catch up also chases after it. It is important to proactively address the ethical, social and regulatory aspects of nanomedicine to minimize its adverse impacts on the environment and public health and to avoid a public backlash. In the next 1015 years, nanotechnology is likely to revolutionize the practice of medicine and have a significant impact on human health. Nanotechnology is already contributing to the development of new drugs, biologics, and medical devices and the augmentation of existing therapeutics. Over 200 companies are involved in nanomedicine research and development. The U.S. Food and Drug Administration has approved nine different types of therapies that employ nanoscale materials, including products used for medical testing and imaging, drug delivery, wound healing, and bone and tissue repair. Discoveries and innovations in nanomedicine have occurred at a breath taking pace in just a short time, uses of nanotechnology in medicine have moved from laboratory testing, to clinical trials, to medical applications.

Track 15: Pharmaceutical Formulations

Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally administered drugs, this usually involves incorporating the drug into a tablet or a capsule. It is important to make the distinction that a tablet contains a variety of other potentially inert substances apart from the drug itself, and studies have to be carried out to ensure that the encapsulated drug is compatible with these other substances in a way that does not cause harm, whether direct or indirect. Formulation studies also consider such factors as particle size, polymorphism, pH, and solubility, as all of these can influence bioavailability and hence the activity of a drug. The drug must be combined with inactive ingredients by a method which ensures that the quantity of drug present is consistent in each dosage unit e.g. each tablet. The dosage should have a uniform appearance, with an acceptable taste, tablet hardness, or capsule disintegration. By the time phase III clinical trials are reached, the formulation of the drug should have been developed to be close to the preparation that will ultimately be used in the market.

Track 16: Applied Pharmaceutical Science

Pharmacy is the science and technique of preparing and dispensing drugs. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. A theory relating chemical structure to pharmaceutical activity emerged from the interplay of experimental results from animal and human tests using vaccines, antitoxins, and antibodies with chemical knowledge about dyes and their molecular structures. Although pharmacology is essential to the study of pharmacy, it is not specific to pharmacy. Pharmacoinformatics is considered as another new discipline, for systematic drug discovery and development with efficiency and safety. The progressively more important role of the chemist and chemical science in pharmaceuticals in the early-20th century is mirrored in the history of the American Chemical Society’s Division of Medicinal Chemistry.

International Conference and Exhibition on Pharmaceutical Nanotechnology and Nanomedicine, (Pharma Nano 2018-USA) scheduled to be held during April 18-19, 2018 Las Vegas, USA. This Pharma Nano 2018 Conference includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and Career development programs. The conference invites delegates from Leading Universities, Pharmaceutical companies, Formulation Scientists, Medical Devices, Researchers, Health care professionals, students, business delegates and Young researchers across the globe providing a better podium, interconnecting the latest research, technological developments in the arena as well as therapeutic aspects. Participating at Nano Medicine 2018 International conference will be an excellent opportunity to meet eminent personalities in the fields of pharmaceutics and learn about the latest technological advancements.

ConferenceSeries.com hosts 3000+ Global Events that includes over 600+ International Conferences, 1200+ Symposiums and 1200+Workshops and preconference workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management fields. Over 25 Million visitors flock to our websites to observe the attest developments in these fields.

Why to Attend???

Pharma Nano 2018-USA Conference is a multidisciplinary program with broad participation with members from around the globe focused on learning about Nano Medicine and its advances. This is your best opportunity to reach the largest assemblage of participants from Nano Medicine community that is from academia, research entities, medical groups, related associations, societies and also from government agencies, pharmaceutical, biomedical and medical device industries.

Who should attend and Who Youll Meet

Directors/Senior Directors/Executive Directors and Vice Presidents/Senior Vice Presidents/Executive Vice Presidents and Heads/Leaders/Partners of

Pharma R&D

CROs and CMOs

Clinical Research Sites

Pharma/Biotech and Medical Device industries

Hospitals, Associations

Medical Directors, Principal Investigators, Methodologists, and other clinical research professionals along with Academicians: University Faculties like Directors, Senior Professors/Assistant Professors/ Associate Professor, Research Scholars, scientists who are related to clinical and medical research. Students also participate at this event as student delegates and young research forum (YRF).

See original here:
Top Nanotechnology Conferences | Top Nanomedicine …

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine – Official Site

The mission of Nanomedicine: Nanotechnology, Biology, and Medicine (Nanomedicine: NBM) is to promote the emerging interdisciplinary field of nanomedicine.

Nanomedicine: NBM is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results…

The mission of Nanomedicine: Nanotechnology, Biology, and Medicine (Nanomedicine: NBM) is to promote the emerging interdisciplinary field of nanomedicine.

Nanomedicine: NBM is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases. In addition to bimonthly issues, the journal website (http://www.nanomedjournal.com) also presents important nanomedicine-related information, such as future meetings, meeting summaries, funding opportunities, societal subjects, public health, and ethical issues of nanomedicine.

The potential scope of nanomedicine is broad, and we expect it to eventually involve all aspects of medicine. Sub-categories include synthesis, bioavailability, and biodistribution of nanomedicines; delivery, pharmacodynamics, and pharmacokinetics of nanomedicines; imaging; diagnostics; improved therapeutics; innovative biomaterials; interactions of nanomaterials with cells, tissues, and living organisms; regenerative medicine; public health; toxicology; point of care monitoring; nutrition; nanomedical devices; prosthetics; biomimetics; and bioinformatics.

Article formats include Communications, Original Articles, Reviews, Perspectives, Technical and Commercialization Notes, and Letters to the Editor. We invite authors to submit original manuscripts in these categories. The journal website (http://www.nanomedjournal.com) also presents important nanomedicine-related information, such as future meetings, meeting summaries, funding opportunities, societal subjects, public health, and ethical issues of nanomedicine.

Read more:
Nanomedicine – Official Site

Recommendation and review posted by Alexandra Lee Anderson

What is Nanomedicine? The future of medicine.

Materials which have at least one dimension less than 100nm are classified as nanomaterials. These materials can be may shapes and sizes like spheres, rods, wires, cubes, plates, stars, cages, pyramids among some funny named shapes like nanohedgehogs, nanocandles and nanocakes! See the paperMorphology-Controlled Growth of ZnO Nanostructures Using Microwave Irradiation: from Basic to Complex Structuresfor some really inventive names for various shaped nanomaterials!

Aside scientists are pretty terrible at naming things, for example,the creative names given to optical telescopes the Extremely Large Telescope,Large Binocular Telescope,Overwhelmingly Large Telescope,Very Large Optical Telescope.

These nanoparticle shapes come in different sizes and different materials too. Broadly we can categorize nanomaterials into two groups organic or inorganic (but it is possible to have a hybrid inorganic-organic nanoparticle too). Organic nanoparticles arent nanoparticles from your local farmers market they are nanoparticles which contain carbon (and often hydrogen too which forms hydrocarbons) whereas most inorganic nanoparticles dont contain carbon atoms. Organic nanomaterials include carbon (except fullerenes) , polymeric and lipid-based nanocarriers. Inorganic nanoparticles include metallic/plasmonic, magnetic, upconversion, semiconductor and silica based nanoparticles.

The main groups of organic nanocarriers are liposomes, micelles, protein/peptide based and dendrimers. Protein/peptide based nanocarriers are amorphous (non-crystalline) materials generally conjugated to the therapeutic agent and is often further functionalised with other molecules. Micelles and liposomes are formed by amphiphilic (both hydrophilic and hydrophobic parts), micelles form monolayers whereas liposomes form bilayers. Lastly, dendrimer nanocarriers are tree-like structures which have a starting atom core (eg. nitrogen) and other elements are added through a series of chemical reactions resulting in a spherical branching structure. This final structure is not unlike blood hemoglobin and albumin macromolecules.

These vesicular nanocarriers can be used to trap both hydrophobic and hydrophilic drugs and even small nanoparticles inside the aqueous/lipid core. This provides protection for drugs and facilitates significant drug loading minimising toxicity and increasing blood circulation time (increasing possibility that the drug will reach the therapeutic target from avoiding opsonisation).

inorganic nanomaterials are stable, robust, resistant, highly functional. and are quite easily cleared from the body. Furthermore, inorganic material exhibit truly exciting mechanical, optical, physical and electrical phenomena at the nanoscale which can be tailored through changes in material, phase, shape, size and surface characteristics. Oftentimes, it is necessary to add a biocompatible surface to inorganic nanoparticles to avoid toxicity, especially for heavy metals.

Semiconductor Nanomaterials

Quantum dots are the most well-known semiconductor nanoemitter. These are typically very small in size ~5nm, which is smaller or equal to the exciton Bohr radius giving quantum confinement. Electrons are subatomic particles with a negative elementary electric charge, electron holes is an empty position in an atom or lattice that an electron could occupy. An exciton is a bound statewhere an electron and electron hole are electrostatically attracted to each other through Coulombic forces.Anexciton bohr radiusis the separation distance between the hole and electron. Due to 3 dimensional confinement effects, quantised energy levels are produced in the filled low energy valence band and in the empty conduction band of the quantum dots which is very unlike bulk semiconductors. The energy gap between the conduction and valance band varies with the size of the quantum dot which explains the tunable emissions (colour) when excited. Additionally, alloyed quantum dots can be further tuned because the bandgap is approximately equal to the weighted average of the composite semiconductor material. Quantum dots excited in the near-infrared are expected to be revolutionary in biomedical imaging. There has been concerns about the stability and toxicity, as many quantum dots lose luminescence intensity when exposed to light/air/oxygen/water and they are generally composed of heavy metal materials.

Upconversion Nanomaterials

Upconversion nanomaterials consist of two parts, first the host dielectric lattice (e.g., NaYF4) with one or more guest trivalent lanthanide (atomic numbers 5771) ions (e.g., Er3+, Yb3+). Upconversion is an anti-stokes process, two or more lower energy photons are absorbed (either simultaneously or stepwise) via long-lived real electronic states of the lanthanide dopant and a higher energy photon is emitted. The lanthanide element has a specific electronic configuration with energy levels which is usually independent of the host material type, the nanoparticle shape and its size.

Electrons are arranged in shells around an atoms nucleus, where the closest electrons to the nucleus have the lowest energy. Each shell can hold a certain number of electrons (principal quantum number) the first shell (1) can hold 2 electrons, the second (2) 8 and the third (3) 18. Within these shells are subshells (defined by theazimuthal quantum number) and are labelled s,p,d or f which can hold 2,6,10 or 14 electrons respectively.

In the case of upconversion, the 5s and 5p shells are full whereas the 4f-4f shells are not. But, because 5s and 5p are full they shield the 4f-4f shells which allows sharp line-like luminescence, i.e. the luminescencepeak is not broad. This luminescence is also resistant to photobleaching, high photostability and are nonblinking, which of course is beneficial over fluorescent molecules which experience high levels of degradation. Through careful design, upconversion nanomaterials can display a variety of emission and excitation wavelengths from UV to NIR.

These upconversion nanoparticles can be incorporated with photosensitizers to produce reactive oxygen species which generally require activation by UV light. This therapy procedure is calledPhotodynamic therapyand can be used for treating a wide range of medical conditions including malignant cancers and acne. Upconverison nanomaterials also have applications in multimodal imaging through the use of specific dopants high atomic number dopants for computed tomography (CT) imaging, radioisotopes for single-photon emission tomography (SPECT) imaging or positron emission tomography(PET) imaging.

MagneticNanomaterials

At the nanoscale, certain magnetic materials below a specific size exhibit a special form of magnetism called superparamagnetism. Superparamagnetic nanoparticles behave as single domain paramagnets when under an external magnetic field but once the field is removed there is no residual magnetisation. Typically, these materials areIron oxide nanoparticles. Additionally, these nanomaterials tend to be non-toxic and can be readily coated with molecules for further functionalization. These nanoparticles are commonly used as MRI contrast agentsinmagnetic resonance imaging (MRI).Furthermore, magnetic nanoparticles can be used in nanotherapy either through magnetic-field-directed drug delivery or through magnetic hyperthermia which involves localized heating of diseased tissues and therefore, cell death.

Silica Nanoparticles

Silica is a highly biocompatible biomaterial which is often used in nanomedicine.

Mesoporous silica nanoparticles are silica nanoparticles which have been template-patterned to have pores throughout the particle. This is done through the use of surfactants likeCetrimonium bromide(CTAB), which is extracted after synthesis leaving holes where the CTAB once was. In these pores, water insoluble materials can be added, such as drugs for chemotherapy, dyes for imaging or even small nanoparticles. These pore sizes can be controlled to encapsulate various sizes of biomolecules. Silica is often used to coat nanoparticles to achieve biocompatibility and to simplify further functionalisation.

PlasmonicNanomaterials

Now, saving the best for last plasmonic nanoparticles.

Plasmonic nanoparticles consist of noble metals like gold, silver, copper and aluminium. At the nanoscale, these materials can supportLocalized surface plasmons, which is a collective oscillation of the free surface electrons at the interface between the nanomaterial and the surrounding dielectric medium when resonance occurs between the natural resonant frequency of the surface electrons and the frequency of the incident light photons. The LSPR can be tuned with the material, size and shape of the nanoparticle.

Plasmonic nanoparticles can scatter and absorb light, for example, for smaller nanoparticles absorption tends to dominate (more light is absorbed which is generally converted to heat energy) and for larger nanoparticles scattering tends to dominate (which is exploited in bioimaging). For this reason, smaller nanoparticles are often used in photothermal therapy. InPhotothermal therapy, plasmonic nanoparticles accumulate in diseased tissues then are irradiated with resonant light, the nanoparticles absorb this light energy and convert it to heat energy, resulting in localised heating of the damaged tissue. This localised heating causes cell death, thus this therapy can be used for cancerous tumors. This heating can be visualised using thermographical measurements or using a dark field microspectroscope, plasmon scattering can be used in medical imaging. Please giveBiomedical applications of plasmon resonant metal nanoparticles, Liao et. al.a read for additional information.

Like Loading…

Read the rest here:
What is Nanomedicine? The future of medicine.

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine Conferences | NanoPharma Conferences 2018 …

Sessions/Tracks

ConferenceSeries Ltdis a renowned organization that organizes highly notableconferencesthroughout the globe. Currently we are bringing forth14thInternational Conference and Exhibition onNanomedicine andPharmaceutical Nanotechnology(NanoMed 2018)scheduled to be held duringApril 16-18, 2018atAmsterdam, Netherlands.The conferenceinvites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical Nanotechnology and Clinical Trials.

The main theme of the conference is Emerging Importance of Nanotechnology to Drive the Pharma Industry.

ConferenceSeries Ltdorganizes aconference seriesof 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientificsocietiesand publishes 700+Open access Journalswhich contains over 50000 eminent personalities, reputed scientists as editorial board members.

14thInternational Conference and Exhibition onNanomedicineandPharmaceutical Nanotechnologyaims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Nanotechnology and Nanomedicine. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields ofNanotechnologyand Nanomedicine.

Medicinehas developed throughout time but has remained forever concerned with the maintenance of health and thus the science of prevention and alleviation, and ultimately curing, of disease. To continue its development in new directions, medicine is now looking to nanomedicine, an emerging scientific specialty born from nanotechnology, which has grown up in the fields ofengineering, physics,chemistryandbiotechnology, and is now moving into medicine, with huge potential for expansion and development over the next decade and beyond.

As our knowledge of the human body continues to improve, nanotechnology will be developed to monitor, repair and control human biological systems at the molecular level. This conference will offer unique opportunities for developing new therapeutic approaches to diagnose, prevent, treat and eradicate life-threatening diseases and conditions (such as cancer and diabetes), as well as resolving pain and improving medical techniques (such as bone repair and surgical techniques), through various novel nanotechnological approaches.

Nanomedicineis a uniquely addressing the important challenges and advances in medicalnanoscale-structured materialand devices,biotechnology devicesand molecular machine systems andnanorobotics. NanoMed 2018 is a valuable information source for all players in the field academic, industrial and clinical researchers, pharmaceutical and biotechnology companies,regulatory authoritiesand others across the scientific community.

Track 1:NanomedicineandBiomedical Applications:

Nanomedicineis simply the application of nanotechnologies in a healthcare setting and the majority of benefits that have already been seen involve the use ofnanoparticlesto improve the behaviour ofdrug substances. Today, nanomedicines are used globally to improve the treatments and lives of patients suffering from a range of disorders including ovarian andbreast cancer, kidney disease, fungal infections,elevated cholesterol, menopausal symptoms, multiple sclerosis, chronic pain,asthmaand emphysema. The nanomedicines that are currently available are overcoming some of the difficulties experienced by normal medical approaches in delivering the benefit from thedrug moleculesused. In some cases the drugs have very little solubility in water and the human body struggles to absorb enough to treat the condition. In other cases, the drug molecule is absorbed well but the body removes the drug before it has had long enough to provide a benefit. Drugs may lead to side-effects due to poor delivery at the actual site of disease. For example, drugs that are targeting cancers must avoid healthy tissues and organs or damage can be caused. Nanomedicines therefore can play an important role in ensuring enough of the drug enters the body, that drug that does enter stays in the body for long periods and is targeted specifically to the areas that need treatment.

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain; 10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany; 23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

Related Societies:

Societies in USA:American Academy of Nanomedicine,Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nano MedicineInternational Association of NanotechnologyandGraphene Stakeholders Association

Societies in Europe:Nanotechnology Industries Association,Royal Microscopical Society,Royal Society – Nanotechnology and Nanoscience,British Society for Nanomedicine,European Society for Nanomedicine,French Society for Nanomedicine,European NanoBusiness Association,European Society for Precision Engineering and Nanotechnology,Czech Nanotechnology Industries AssociationandErwin Schrdinger Society for Nanosciences

Societies in Asia:National Center for Nanoscience and Technology,Indian Society for Nanomedicine,Nano Technology Research AssociationandIndian Society of Nanomedicine.

Track 2:Design of Nanodrugs

To date, variousnanodrug systemshave been developed for different routes of administration, which include dendrimers,nanocrystals, emulsions, liposomes, solid lipid nanoparticles, micelles, and polymeric nanoparticles. Nanodrug systems have been employed to improve the efficacy, safety, physicochemical properties, and pharmacokinetic/pharmacodynamic profile of pharmaceutical substances. In particular, functionalized nanodrug systems can offer enhancedbioavailabilityof orally taken drugs, prolonged half-life of injected drugs (by reducing immunogenicity), andtargeted delivery to specific tissues. Thus,nanodrug systemsmight lower the frequency of administration while providing maximized pharmacological effects and minimized systemic side effects, possibly leading to better therapeutic compliance and clinical outcomes. In spite of these attractive pharmacokinetic advantages, recent attention has been drawn to the toxic potential of nanodrugs since they often exhibit in vitro and in vivo cytotoxicity, oxidative stress, inflammation, and genotoxicity

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain; 10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany; 23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

Related Societies:

Societies in USA:American Academy of Nanomedicine,Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nano MedicineInternational Association of NanotechnologyandGraphene Stakeholders Association

Societies in Europe:Nanotechnology Industries Association,Royal Microscopical Society,Royal Society – Nanotechnology and Nanoscience,British Society for Nanomedicine,European Society for Nanomedicine,French Society for Nanomedicine,European NanoBusiness Association,European Society for Precision Engineering and Nanotechnology,Czech Nanotechnology Industries AssociationandErwin Schrdinger Society for Nanosciences

Societies in Asia:National Center for Nanoscience and Technology,Indian Society for Nanomedicine,Nano Technology Research AssociationandIndian Society of Nanomedicine.

Track 3:Design & Characterization of Nanosystems

Micro andNanosystemspublishes significant original work, topical reviews and guest edited issues ranging from technologies and systems to product innovation and new manufacturing processes with features at the micro and nanoscale. Applications for micro and nanosystems in areas such as health, environment, food, security and consumer goods are covered. The topics to be addressed include Lab-on-a-chip,microfluidics, nano-biotechnology, micro andnanomanufacturing, printed electronics and MEMS.

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain; 10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany; 23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

Related Societies:

Societies in USA:American Academy of Nanomedicine,Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nano MedicineInternational Association of NanotechnologyandGraphene Stakeholders Association

Societies in Europe:Nanotechnology Industries Association,Royal Microscopical Society,Royal Society – Nanotechnology and Nanoscience,British Society for Nanomedicine,European Society for Nanomedicine,French Society for Nanomedicine,European NanoBusiness Association,European Society for Precision Engineering and Nanotechnology,Czech Nanotechnology Industries AssociationandErwin Schrdinger Society for Nanosciences

Societies in Asia:National Center for Nanoscience and Technology,Indian Society for Nanomedicine,Nano Technology Research AssociationandIndian Society of Nanomedicine.

Track 4:NanomedicineandNanotechnology

Nanomedicine is a branch of medicine that applies the knowledge and tools of nanotechnology to the prevention and treatment of disease. Nanomedicine involves the use ofnanoscale materials, such as biocompatible nanoparticles andnanorobots, for diagnosis, delivery, sensing or actuation purposes in a living organism.Nanotechnologyhas many definitions but in general it is the use and application of materials with sizes in the nanometre range. Just as a millimetre is one-thousandth of a metre, a nanometre is one-millionth of a millimetre. In more understandable terms, a human hair is approximately 80,000 nanometres in diameter and the growing science and industry of nanotechnology utilises materials below 1000 nanometres. Benefits of working at this very small scale have been seen for many years over such diverse areas as electronics and energy storage to sunscreens and food packaging.

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain; 10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany; 23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

Related Societies:

Societies in USA:American Academy of Nanomedicine,Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nano MedicineInternational Association of NanotechnologyandGraphene Stakeholders Association

Societies in Europe:Nanotechnology Industries Association,Royal Microscopical Society,Royal Society – Nanotechnology and Nanoscience,British Society for Nanomedicine,European Society for Nanomedicine,French Society for Nanomedicine,European NanoBusiness Association,European Society for Precision Engineering and Nanotechnology,Czech Nanotechnology Industries AssociationandErwin Schrdinger Society for Nanosciences

Societies in Asia:National Center for Nanoscience and Technology,Indian Society for Nanomedicine,Nano Technology Research AssociationandIndian Society of Nanomedicine.

Track 5:Pharmaceutical Nanotechnology

Pharmaceutical Nanotechnologydeals with emerging new technologies for developing customized solutions fordrug delivery systems. The drug delivery system positively impacts the rate of absorption, distribution, metabolism, and excretion of the drug or other related chemical substances in the body. In addition to this the drug delivery system also allows the drug to bind to its target receptor and influence that receptors signaling and activity. Pharmaceutical nanotechnology embraces applications of nanoscience to pharmacy asnanomaterials, and as devices likedrug delivery, diagnostic, imaging and biosensor.

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain; 10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany; 23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

Related Societies:

Societies in USA:American Academy of Nanomedicine,Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nano MedicineInternational Association of NanotechnologyandGraphene Stakeholders Association

Societies in Europe:Nanotechnology Industries Association,Royal Microscopical Society,Royal Society – Nanotechnology and Nanoscience,British Society for Nanomedicine,European Society for Nanomedicine,French Society for Nanomedicine,European NanoBusiness Association,European Society for Precision Engineering and Nanotechnology,Czech Nanotechnology Industries AssociationandErwin Schrdinger Society for Nanosciences

Societies in Asia:National Center for Nanoscience and Technology,Indian Society for Nanomedicine,Nano Technology Research AssociationandIndian Society of Nanomedicine.

Track 6:Synthesis of NanoparticlesforDrug Delivery

Synthesizingnanoparticlesfor pharmaceutical purposes such as drug preparation can be done in two methods. Bottom up process such as pyrolysis, inert gas condensation, solvothermal reaction, sol-gel fabrication and structured media in which hydrophobic compound such asliposomesare used as bases to mount the drug. Top down process such as attrition / milling in which the drug is chiseled down to form a nanoparticle.

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain; 10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany; 23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

Related Societies:

Societies in USA:American Academy of Nanomedicine,Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nano MedicineInternational Association of NanotechnologyandGraphene Stakeholders Association

Societies in Europe:Nanotechnology Industries Association,Royal Microscopical Society,Royal Society – Nanotechnology and Nanoscience,British Society for Nanomedicine,European Society for Nanomedicine,French Society for Nanomedicine,European NanoBusiness Association,European Society for Precision Engineering and Nanotechnology,Czech Nanotechnology Industries AssociationandErwin Schrdinger Society for Nanosciences

Societies in Asia:National Center for Nanoscience and Technology,Indian Society for Nanomedicine,Nano Technology Research AssociationandIndian Society of Nanomedicine.

Track 7:Regenerative MedicineandTissue Engineering

Tissue engineeringis a branch of regenerative medicine, itself a branch ofbiomedical engineering. Tissue engineering andregenerative medicineare concerned with the replacement or regeneration of cells, tissues (the focus of tissue engineers) or organs to restore normal biological function.

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain;Nanomedicine Conferences 2018 USA;10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany;Nanomedicine Conferences 2018 Asia;23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Nanomedicine Conferences 2018 Asia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

Related Societies:

Societies in USA:American Academy of Nanomedicine,Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nano MedicineInternational Association of NanotechnologyandGraphene Stakeholders Association

Societies in Europe:Nanotechnology Industries Association,Royal Microscopical Society,Royal Society – Nanotechnology and Nanoscience,British Society for Nanomedicine,European Society for Nanomedicine,French Society for Nanomedicine,European NanoBusiness Association,European Society for Precision Engineering and Nanotechnology,Czech Nanotechnology Industries AssociationandErwin Schrdinger Society for Nanosciences

Societies in Asia:National Center for Nanoscience and Technology,Indian Society for Nanomedicine,Nano Technology Research AssociationandIndian Society of Nanomedicine.

Track 8:Drug Delivery Research

Drug deliveryis an essential part ofpharmaceutical sciencesthat should be taken into account early in thedrug discoveryand development process. A drug that cannot be delivered to its site of action is essentially useless. Drug delivery is affected by the physico-chemical properties of the drug and formulation and the interplay of these factors with the transport, binding, and metabolism of the drug in the body. New tools are needed to accurately predict delivery properties of the compounds early during drug discovery, so that the best compounds can be identified for clinical studies. Another class of tools includes the delivery methods that facilitate delivery of hard-to-deliver compounds to the appropriate target sites. Delivery of gene-based drugs (DNA, oligonucleotides, siRNA) and proteins is a major challenge in pharmaceutical science. Nanotechnology can be used to improve drug delivery in these difficult cases. The development and use of nanoparticles in theformulationof these types of drugs is a major focus at CDR, and we welcome productive industrial partnerships to develop these tools for translational use.

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain;Nanomedicine Conferences 2018 USA;10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany;Nanomedicine Conferences 2018 Asia;23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Nanomedicine Conferences 2018 Asia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

Related Societies:

Societies in USA:American Academy of Nanomedicine,Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nano MedicineInternational Association of NanotechnologyandGraphene Stakeholders Association

Societies in Europe:Nanotechnology Industries Association,Royal Microscopical Society,Royal Society – Nanotechnology and Nanoscience,British Society for Nanomedicine,European Society for Nanomedicine,French Society for Nanomedicine,European NanoBusiness Association,European Society for Precision Engineering and Nanotechnology,Czech Nanotechnology Industries AssociationandErwin Schrdinger Society for Nanosciences

Societies in Asia:National Center for Nanoscience and Technology,Indian Society for Nanomedicine,Nano Technology Research AssociationandIndian Society of Nanomedicine.

Track 9:Novel Drug Delivery Systems

Novel Drug delivery systemis the advancedrug delivery systemwhich improvedrug potency,control drug releaseto give a sustained therapeutic effect, provide greater safety, finally it is to target a drug specifically to a desired tissue.

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain;Nanomedicine Conferences 2018 USA;10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany;Nanomedicine Conferences 2018 Asia;23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Nanomedicine Conferences 2018 Asia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

Related Societies:

Societies in USA:American Academy of Nanomedicine,Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nano MedicineInternational Association of NanotechnologyandGraphene Stakeholders Association

Societies in Europe:Nanotechnology Industries Association,Royal Microscopical Society,Royal Society – Nanotechnology and Nanoscience,British Society for Nanomedicine,European Society for Nanomedicine,French Society for Nanomedicine,European NanoBusiness Association,European Society for Precision Engineering and Nanotechnology,Czech Nanotechnology Industries AssociationandErwin Schrdinger Society for Nanosciences

Societies in Asia:National Center for Nanoscience and Technology,Indian Society for Nanomedicine,Nano Technology Research AssociationandIndian Society of Nanomedicine.

Track 10:Smart Drug Delivery Technology

With the unprecedented progresses ofbiomedical nanotechnologyduring the past few decades, conventionaldrug delivery systems(DDSs) have been involved into smart DDSs with stimuli-responsive characteristics. Benefiting from the response to specific internal or external triggers, those well-defined nanoplatforms can increase the drug targeting efficacy, in the meantime; reduce side effects/toxicities of payloads, which are key factors for improving patient compliance. In academic field, variety of smart DDSs have been abundantly demonstrated for various intriguing systems, such as stimuli-responsivepolymeric nanoparticles, liposomes, metals/metal oxides, and exosomes.

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain;Nanomedicine Conferences 2018 USA;10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany;Nanomedicine Conferences 2018 Asia;23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Nanomedicine Conferences 2018 Asia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

Related Societies:

Societies in USA:American Academy of Nanomedicine,Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nano MedicineInternational Association of NanotechnologyandGraphene Stakeholders Association

Societies in Europe:Nanotechnology Industries Association,Royal Microscopical Society,Royal Society – Nanotechnology and Nanoscience,British Society for Nanomedicine,European Society for Nanomedicine,French Society for Nanomedicine,European NanoBusiness Association,European Society for Precision Engineering and Nanotechnology,Czech Nanotechnology Industries AssociationandErwin Schrdinger Society for Nanosciences

Societies in Asia:National Center for Nanoscience and Technology,Indian Society for Nanomedicine,Nano Technology Research AssociationandIndian Society of Nanomedicine.

Track 11:Nano Pharmaceuticals

Nanopharmaceuticalsoffer the ability to detect diseases at much earlier stages and the diagnostic applications could build upon conventional procedures using nanoparticles. Nanopharmaceuticals represent an emerging field where the sizes of thedrug particleor a therapeutic delivery system work at thenanoscale. In the pharmaceutical industry, a long standing issue is the difficulty of delivering the appropriate dose of a particular active agent to specific disease site. Nanopharmaceuticals have enormous potential in addressing this failure of traditional therapeutics which offers site-specific targeting of active agents. Such precision targeting via nanopharmaceuticals reduces toxic systemic side effects, resulting in better patient compliance. In todays world economy, apharmaceutical industryfaces enormous pressure to deliver high-quality products to patients while maintaining profitability. Thereforepharmaceutical companiesare applying nanotechnology to enhance or supplement drug target discovery anddrug delivery. Nanopharmaceutical reduces the cost of drug discovery, design & development and enhances the drug delivery process. This results in the improvedResearch & Developmentsuccess rate which enables faster introduction of new, cost-effective products to the marketplace.

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain;Nanomedicine Conferences 2018 USA;10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany;Nanomedicine Conferences 2018 Asia;23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Nanomedicine Conferences 2018 Asia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

Related Societies:

Societies in USA:American Academy of Nanomedicine,Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nano MedicineInternational Association of NanotechnologyandGraphene Stakeholders Association

Societies in Europe:Nanotechnology Industries Association,Royal Microscopical Society,Royal Society – Nanotechnology and Nanoscience,British Society for Nanomedicine,European Society for Nanomedicine,French Society for Nanomedicine,European NanoBusiness Association,European Society for Precision Engineering and Nanotechnology,Czech Nanotechnology Industries AssociationandErwin Schrdinger Society for Nanosciences

Societies in Asia:National Center for Nanoscience and Technology,Indian Society for Nanomedicine,Nano Technology Research AssociationandIndian Society of Nanomedicine.

Track 12:Nanobiotechnology

Nanobiotechnology,bionanotechnology, and nanobiology are terms that refer to the intersection of nanotechnology andbiology. This discipline helps to indicate the merger of biological research with various fields of nanotechnology. Concepts that are enhanced throughnanobiologyinclude:nanodevices(such asbiological machines), nanoparticles, and nanoscale phenomena that occurs within the discipline of nanotechnology. This technical approach to biology allows scientists to imagine and create systems that can be used forbiological research. Biologically inspired nanotechnology uses biological systems as the inspirations for technologies not yet created.

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain;Nanomedicine Conferences 2018 USA;10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany;Nanomedicine Conferences 2018 Asia;23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Nanomedicine Conferences 2018 Asia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

See the original post here:
Nanomedicine Conferences | NanoPharma Conferences 2018 …

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine – Overview

The program began in 2005 with a national network ofeight Nanomedicine Development Centers. Now, in the second half of this 10-year program, the four centers best positioned to effectively apply their findings to translational studies were selected to continue receiving support.

Nanomedicine, an offshoot of nanotechnology, refers to highly specific medical intervention at the molecular scale for curing disease or repairing damaged tissues, such as bone, muscle, or nerve. A nanometer is one-billionth of a meter, too small to be seen with a conventional lab microscope. It is at this size scale about 100 nanometers or less that biological molecules and structures operate in living cells.

The NIH vision for Nanomedicine is built upon the strengths of NIH funded researchers in probing and understanding the biological, biochemical and biophysical mechanisms of living tissues. Since the cellular machinery operates at the nanoscale, the primary goal of the program – characterizing the molecular components inside cells at a level of precision that leads to re-engineering intracellular complexes – is a monumental challenge.

The teams selected to carry out this initiative consist of researchers with deep knowledge of biology and physiology, physics, chemistry, math and computation, engineering, and clinical medicine. The choice and design of experimental approaches are directed by the need to solve clinical problems (e.g., treatment of sickle cell disease, blindness, cancer, and Huntingtons disease). These are very challenging problems, and great breakthroughs are needed to achieve the goals within the projected 10 year timeframe. The initiative was selected for the NIH Roadmap (now Common Fund) precisely because of the challenging, high risk goals, and the NIH team is working closely with the funded investigators to use the funds and the intellectual resources of the network of investigators to meet those challenges.

10 Year Program Design High Risk, High Reward

The Centers were funded with the expectation that the first half of the initiative would be more heavily focused on basic science with increased emphasis on application of this knowledge in the second five years. This was a novel, experimental approach to translational medicine that began by funding basic scientists interested in gaining a deep understanding of an intracellular nanoscale system and necessitated collaboration with clinicians from the outset in order to properly position work at the centers so that during the second half of the initiative, studies would be applied directly to medical applications. The program began witheight Nanomedicine Development Centers(NDCs), and four centers remain in the second half of the program.

Clinical Consulting Boards (CCBs)

The program has establishedClinical Consulting Boards (CCBs)for each of the continuing centers. These boards consist of at least three disease-specific clinician-scientists who are experts in the target disease(s). The intent is for CCBs to provide advice and insight into the needs and barriers regarding resource and personnel allocations as well as scientific advice as needed to help the centers reach their translational goals. Each CCB reports directly to the NIH project team.

Translational Path

In 2011, the PIs of the NDCs worked with their CCBs to precisely define their translational goals and the translational research path needed to reach those goals by the end of the initiative in 2015. To facilitate this, the NIH project team asked them to developcritical decision pointsalong their path. These critical decision points differ from distinct milestones because they may be adjusted based on successes, challenges, barriers, and progress. Similarly, the timing of these decision points may be revised as the centers progress. Research progress and critical decision points are revisited several times a year by the CCB and the NIH team, and when a decision point is reached, next steps are re-examined for relevance, feasibility and timing.

Transition plan

Throughout the program, various projects have been spun off of work at all the centers and most have received funding from other sources. This was by design as work at each center has been shifting from basic science to translational studies. Centers will not be supported by the common fund after 10 years. It is expected that work at the centers will be more appropriately funded by other sources. Pre-clinical targets will likely be developed, and the work at each center will be focused on a specific disease so the work will need to transition out of the experimental space of the common fund.

Support for the NIH Nanomedicine Initiative is provided by the NIH Common Fund, and a team of staff members from across the NIH oversees the program. You may direct questions or comments on the NIH Nanomedicine Initiative to Dr. Richard S. Fisher, Nanomedicine Project Team Leader (nano@nih.gov).

More here:
Nanomedicine – Overview

Recommendation and review posted by Alexandra Lee Anderson